Stellar Biotechnologies Inc (NASDAQ:SBOT)’s share price rose 10.9% during mid-day trading on Friday . The company traded as high as $1.14 and last traded at $1.12. Approximately 559,637 shares traded hands during mid-day trading, an increase of 34% from the average daily volume of 417,659 shares. The stock had previously closed at $1.01.
Separately, ValuEngine upgraded shares of Stellar Biotechnologies from a “hold” rating to a “buy” rating in a research report on Thursday, November 1st.
About Stellar Biotechnologies (NASDAQ:SBOT)
Stellar Biotechnologies, Inc, a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein in Europe, North America, and Asia. The company offers KLH, an immune-stimulating protein used in the production of various immunotherapies; and as a carrier molecule or finished injectable product in the immunodiagnostic market.
Receive News & Ratings for Stellar Biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stellar Biotechnologies and related companies with MarketBeat.com's FREE daily email newsletter.